Ibironke Vivian Adelaja, MD
General Surgery · Clovis
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Community Health Partners · 497 clinicians in this group
Hospitals listed: Adventist Health Hanford · Clovis Community Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Adelaja’s office at (559) 256-4111 to ask if they take your plan before you enroll.
California Medical Board record
Licence A102787 · Current
Licensed to practise in California · since 2008 · expires 2027-08-31 · Texas A & M University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health HanfordHanford, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 65% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.277, Oct 2024 – Sep 2025
- Clovis Community Medical CenterClovis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (12.1 to 17.7) · 421 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.692, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Hanford
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.277 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.91) · 614 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.38 to 1.15) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 190.5 (130.11 to 250.89) · 29 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 101 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.4 · 43 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.5 · 269 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.8 · 376 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.2 · 145 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 1,486 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,684 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.08 to 0.49) · 3,819 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.67 (0.36 to 4.98) · 613 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.32) · 154 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.65 (1.02 to 4.28) · 598 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.24 (0 to 16.19) · 160 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.85 (0.67 to 9.03) · 147 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 1) · 3,186 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.418 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.574 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.182 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.8 · 38 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 328 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 14.5 · 302 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 22 · 380 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 407 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 113 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10 to 17) · 896 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 228 cases | No different | Jan 2024 – Dec 2024 |
What patients said (947 patients answered, 13% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 65% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Clovis Community Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.7 (12.1 to 17.7) · 421 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.692 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.04 to 1.89) · 1,840 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.86 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 217.06 (167.45 to 266.67) · 84 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 507 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 798 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 336 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 3,771 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 8,649 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,146 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.47 to 5.45) · 1,654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.19 (0.61 to 3.78) · 387 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.7 to 3.66) · 1,578 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.47 (7.08 to 19.87) · 374 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (1.37 to 8.61) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.04) · 405 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.8 (0.23 to 1.38) · 8,198 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 90 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.922 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.449 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.509 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 210 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 58.4 · 556 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18 · 769 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 802 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4 to 7.4) · 421 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.8 to 15.6) · 2,398 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 720 cases | No different | Jan 2024 – Dec 2024 |
What patients said (441 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$69,905
Medicare paid this office $69,905 for 247 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 168 | $17,250 | $97 |
| Simple complete removal of breast | 17 | $14,539 | $855 |
| Partial removal of breast | 21 | $10,926 | $520 |
| New patient visit (60+ min) | 30 | $5,211 | $174 |
| Biopsy or removal of deep lymph nodes of underarm | 26 | $4,919 | $189 |
See all 9 services
| Return visit (30+ min) | 168 | $17,250 | $97 |
| Simple complete removal of breast | 17 | $14,539 | $855 |
| Partial removal of breast | 21 | $10,926 | $520 |
| New patient visit (60+ min) | 30 | $5,211 | $174 |
| Biopsy or removal of deep lymph nodes of underarm | 26 | $4,919 | $189 |
| Short return visit (20+ min) | 59 | $4,569 | $74 |
| Imaging of lymph nodes during surgery | 28 | $2,895 | $103 |
| Long return visit (40+ min) | 13 | $1,634 | $126 |
| Injection of radioactive material for x-ray identification of lymph node | 27 | $345 | $13 |
Procedures Medicare counted
| Mastectomy | 56 | More than 96% of doctors who do this |
| Melanoma (skin cancer) excision | 1-10 | None |
Who their Medicare patients are
247 Original Medicare patients in 2024. Average age 73 · Under 65 8% · 85 and older 8% · Also on Medicaid 23% · Health risk score 1.09. At or below the middle of the specialty; the typical general surgery clinician is at 1.69.
Conditions among them: High blood pressure 75% · Cancer 75% · Diabetes 33% · Coronary heart disease 27% · Chronic kidney disease 24% · Depression 20% · Heart failure 14% · COPD 13% · Atrial fibrillation 11% · Stroke 5%.
The office billed $283,205, Medicare allowed $90,280 and paid $69,905; for 448 services of 26 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 247 | 448 | 73 | 1.09 | $283,205 | $69,905 |
| 2023 | 235 | 567 | 73 | 1.08 | $355,637 | $85,912 |
| 2022 | 240 | 663 | 73 | 0.94 | $438,811 | $108,655 |
| 2021 | 223 | 603 | 72 | 1.11 | $358,857 | $91,830 |
| 2020 | 212 | 571 | 72 | 1.24 | $390,015 | $106,775 |
| 2019 | 113 | 344 | 69 | 1.82 | $194,170 | $57,750 |
| 2018 | 96 | 240 | 70 | 1.67 | $128,391 | $40,172 |
| 2017 | 110 | 283 | 67 | 1.55 | $155,255 | $43,427 |
| 2016 | 48 | 158 | 67 | 1.62 | $103,423 | $35,970 |
| 2015 | 47 | 134 | 65 | 2.06 | $93,605 | $32,291 |
| 2013 | 34 | 51 | 67 | 2.28 | $19,064 | $6,645 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 176 | $20,882 | $94 |
| Simple complete removal of breast | 19 | $16,266 | $856 |
| Partial removal of breast | 28 | $14,459 | $499 |
| New patient visit (60+ min) | 45 | $7,716 | $171 |
| Biopsy or removal of deep lymph nodes of underarm | 31 | $5,241 | $169 |
| Short return visit (20+ min) | 61 | $5,065 | $68 |
| Imaging of lymph nodes during surgery | 35 | $3,571 | $102 |
| Long return visit (40+ min) | 22 | $3,040 | $132 |
| New patient visit (45+ min) | 15 | $1,489 | $99 |
| Injection of radioactive material for x-ray identification of lymph node | 31 | $395 | $13 |
2022: 11 services
| Partial removal of breast | 42 | $26,463 | $499 |
| Return visit (30+ min) | 133 | $16,872 | $100 |
| Simple complete removal of breast | 17 | $14,618 | $860 |
| Long return visit (40+ min) | 59 | $10,463 | $145 |
| New patient visit (60+ min) | 56 | $9,733 | $174 |
| Biopsy or removal of deep lymph nodes of underarm | 40 | $7,754 | $189 |
| Short return visit (20+ min) | 77 | $6,173 | $68 |
| Imaging of lymph nodes during surgery | 43 | $4,675 | $109 |
| New patient visit (45+ min) | 28 | $3,189 | $114 |
| Telephone medical discussion with physician, 21-30 minutes | 25 | $3,095 | $103 |
| Injection of radioactive material for x-ray identification of lymph node | 40 | $542 | $14 |
2021: 12 services
| Partial removal of breast | 36 | $21,411 | $549 |
| Short return visit (20+ min) | 118 | $13,087 | $73 |
| Simple complete removal of breast | 15 | $12,217 | $814 |
| Return visit (30+ min) | 81 | $10,433 | $105 |
| New patient visit (60+ min) | 31 | $5,749 | $185 |
| Biopsy or removal of deep lymph nodes of underarm | 29 | $5,379 | $185 |
| Long return visit (40+ min) | 29 | $5,171 | $148 |
| New patient visit (45+ min) | 36 | $4,812 | $134 |
| Telephone medical discussion with physician, 21-30 minutes | 35 | $3,800 | $95 |
| Imaging of lymph nodes during surgery | 25 | $2,838 | $114 |
| New patient visit (30+ min) | 14 | $808 | $58 |
| Injection of radioactive material for x-ray identification of lymph node | 23 | $314 | $14 |
2020: 15 services
| Partial removal of breast | 37 | $19,674 | $504 |
| Simple complete removal of breast | 15 | $12,362 | $824 |
| New patient visit (60+ min) | 66 | $11,078 | $168 |
| Long return visit (40+ min) | 38 | $6,219 | $117 |
| Partial removal of breast | 13 | $5,689 | $438 |
| Biopsy or removal of deep lymph nodes of underarm | 24 | $4,844 | $202 |
| Short return visit (20+ min) | 66 | $4,642 | $60 |
| New patient visit (30+ min) | 49 | $4,385 | $89 |
| New patient visit (45+ min) | 28 | $3,518 | $126 |
| Imaging of lymph nodes during surgery | 29 | $3,419 | $118 |
| Return visit (30+ min) | 27 | $2,439 | $81 |
| Extended office or other outpatient service, first hour | 16 | $1,860 | $109 |
| Limited ultrasound scan of 1 breast | 14 | $1,056 | $66 |
| Injection of radioactive material for x-ray identification of lymph node | 23 | $325 | $14 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $220 | $20 |
2019: 9 services
| Partial removal of breast | 17 | $10,642 | $532 |
| Long return visit (40+ min) | 55 | $8,580 | $118 |
| New patient visit (60+ min) | 41 | $6,827 | $167 |
| Biopsy or removal of deep lymph nodes of underarm | 18 | $3,345 | $186 |
| Return visit (30+ min) | 27 | $2,562 | $88 |
| Short return visit (20+ min) | 27 | $1,972 | $56 |
| Imaging of lymph nodes during surgery | 18 | $1,965 | $109 |
| New patient visit (45+ min) | 13 | $1,473 | $113 |
| Limited ultrasound scan of 1 breast | 16 | $1,209 | $76 |
2018: 6 services
| Long return visit (40+ min) | 41 | $7,049 | $112 |
| New patient visit (60+ min) | 20 | $2,972 | $149 |
| Biopsy or removal of deep lymph nodes of underarm | 12 | $2,191 | $183 |
| New patient visit (45+ min) | 16 | $2,145 | $134 |
| Return visit (30+ min) | 18 | $1,855 | $77 |
| Imaging of lymph nodes during surgery | 14 | $1,537 | $110 |
2017: 6 services
| Long return visit (40+ min) | 44 | $7,415 | $114 |
| New patient visit (60+ min) | 34 | $5,528 | $163 |
| Long return visit (40+ min) | 11 | $1,236 | $88 |
| Limited ultrasound scan of 1 breast | 15 | $1,168 | $73 |
| Return visit (30+ min) | 11 | $1,039 | $87 |
| Short return visit (20+ min) | 13 | $766 | $55 |
2016: 2 services
| Long return visit (40+ min) | 20 | $4,152 | $112 |
| New patient visit (60+ min) | 22 | $3,707 | $168 |
2015: 3 services
| New patient visit (60+ min) | 14 | $2,228 | $159 |
| Long return visit (40+ min) | 12 | $1,901 | $119 |
| New patient visit (45+ min) | 12 | $1,595 | $133 |
2013: 1 service
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $981 | $31 |
Medicaid work
$83,641 in 2024
Medicaid paid $83,641 for 1,276 billed services this clinician did in 2024, up to 38 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 297 | $82,263 |
| Return visit (30+ min) | 254 | $1,157 |
| Short return visit (20+ min) | 105 | $220 |
| Medication list documented in medical record (COA) | 250 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 249 | $0 |
| BODY MASS INDEX DOCD | 121 | $0 |
| 2024 | 1,276 | 6 | 38 | $83,641 |
| 2023 | 758 | 6 | 23 | $68,849 |
| 2022 | 745 | 6 | 29 | $64,596 |
| 2021 | 693 | 4 | 38 | $153,965 |
| 2020 | 914 | 5 | 55 | $165,262 |
| 2019 | 715 | 3 | 52 | $117,251 |
| 2018 | 237 | 2 | 38 | $36,141 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 249 | $68,369 |
| Return visit (30+ min) | 157 | $480 |
| Medication list documented in medical record (COA) | 134 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 133 | $0 |
| BODY MASS INDEX DOCD | 58 | $0 |
| Short return visit (20+ min) | 27 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 238 | $64,559 |
| Return visit (30+ min) | 28 | $38 |
| Medication list documented in medical record (COA) | 172 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 172 | $0 |
| BODY MASS INDEX DOCD | 102 | $0 |
| Short return visit (20+ min) | 33 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 549 | $153,870 |
| Short return visit (20+ min) | 100 | $95 |
| New patient visit (45+ min) | 17 | $0 |
| Return visit (30+ min) | 27 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 643 | $165,262 |
| New patient visit (30+ min) | 15 | $0 |
| Short return visit | 69 | $0 |
| Short return visit (20+ min) | 169 | $0 |
| Return visit (30+ min) | 18 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 630 | $117,251 |
| Short return visit (20+ min) | 68 | $0 |
| Return visit (30+ min) | 17 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 224 | $35,718 |
| Long return visit (40+ min) | 13 | $423 |
Drugs they prescribed that Part D paid
$2,209
Pharmacies billed $2,209 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 26% of their Part D prescriptions (20 of 77) in 2024. At or below the middle of the specialty; the typical general surgery clinician is at 34%.
77 generic and 0 brand-name prescriptions · $2,209 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gabapentin | 13 | $200 | $11 |
| Hydrocodone-Acetaminophen | 14 | $132 | $8 |
Year by year
| 2024 | 77 | 31 | 26% (20) | 0% | $2,209 |
| 2023 | 80 | 41 | 24% (19) | None | $1,500 |
| 2022 | 82 | 43 | 17% (14) | None | $2,542 |
| 2021 | 87 | 46 | 33% (29) | 0% | $1,599 |
| 2020 | 113 | 67 | 51% (58) | None | $923 |
| 2019 | 48 | 33 | 54% (26) | 0% | $337 |
| 2018 | 26 | 19 | 46% (12) | 0% | $210 |
| 2017 | 70 | 40 | 56% (39) | None | $4,930 |
| 2016 | 50 | 24 | 36% (18) | None | $2,222 |
| 2015 | 52 | 28 | 60% (31) | None | $6,189 |
| 2014 | 15 | None | None | None | $1,579 |
| 2013 | 15 | 11 | None | 0% | $181 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Celecoxib | 14 | $606 | $43 |
| Gabapentin | 11 | $128 | $12 |
| Hydrocodone-Acetaminophen | 12 | $54 | $5 |
2022: 2 drugs
| Gabapentin | 11 | $89 | $8 |
| Hydrocodone-Acetaminophen | 12 | $71 | $6 |
2021: 2 drugs
| Gabapentin | 11 | $124 | $11 |
| Hydrocodone-Acetaminophen | 24 | $122 | $5 |
2020: 3 drugs
| Hydrocodone-Acetaminophen | 27 | $194 | $7 |
| Gabapentin | 15 | $120 | $8 |
| Tramadol | 25 | $71 | $3 |
2019: 1 drug
| Tramadol | 15 | $39 | $3 |
2017: 1 drug
| Hydrocodone-Acetaminophen | 30 | $177 | $6 |
2015: 1 drug
| Hydrocodone-Acetaminophen | 18 | $189 | $10 |
Money from drug and device companies
$261 in 2025
| 2025 | 3 | 3 | None | $261 |
| 2024 | 1 | 1 | None | $21 |
| 2023 | 1 | 1 | None | $29 |
| 2021 | 1 | 1 | None | $134 |
| 2020 | 3 | 5 | None | $208 |
| 2019 | 2 | 3 | None | $146 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Hologic Sales and Service | Magtrace | $128 | 1 payment
|
| Elucent Medical | None | $111 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $22 | 1 payment
|
See all 3 published payments
| Tactile Systems Technology | Meals · 2025-12-01 | Flexitouch Plus | $22 |
| Hologic Sales and Service | Meals · 2025-03-06 | Magtrace | $128 |
| Elucent Medical | Meals · 2025-03-06 | None | $111 |
See earlier years (2024, 2023, 2021, 2020, 2019)
2024: $21
| Myriad Genetic Laboratories | Myrisk | $21 | 1 payment
|
2023: $29
| Alnylam Pharmaceuticals | Onpattro | $29 | 1 payment
|
2021: $134
| Sientra | Sientra High Strength Cohesive Silicone Gel Breast Implant | $134 | 1 payment
|
2020: $208
| Sientra | Sientra High Strength Cohesive Silicone Gel Breast Implant | $132 | 1 payment
|
| Boston Scientific | General - Pain Management | $60 | 3 payments
|
| Davol | Progel | $17 | 1 payment
|
2019: $146
| Smith+Nephew | Pico 7 Single Use Negative Pressure Wound Therapy | $122 | 2 payments
|
| AbbVie | Creon | $24 | 1 payment
|
Professional record
- NPI
- 1417118159
- Licence
- CA A102787California A102787: Current · expires 2027-08-31
- Trained
- Texas A & M University System, Hsc, College of Medicine, 2006
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Surgery (208600000X)
- Mailing address
- 2625 E Divisadero St, Fresno, CA, 93721
- NPI first listed
- 2008-06-24
- NPI last updated
- 2024-11-27
- NPI record certified
- 2024-11-27
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 782 Medical Center Dr E Ste 101, Clovis, CA, 93611